Insiders · PLYX

PLYX insider transactions

Polaryx Therapeutics Inc. (PLYX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PLYX

• 64d
  Chief Financial Officer Landis G. Michael bought $7,991 worth of shares (2,867 units at $2.79), increasing direct ownership by 1% to 228,225 units (SEC Form 4)

  4 - Polaryx Therapeutics, Inc. (0002075320) (Issuer)